Related Experiment Video
Updated: May 21, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind,
M Kumpu1, R A Kekkonen, H Kautiainen
1Valio Ltd, Helsinki, Finland.
Insights
Daily consumption of probiotic Lactobacillus rhamnosus GG (GG) in milk reduced respiratory illness in children attending day care, particularly when GG was detected in fecal samples. Further research is needed to confirm this probiotic effect.
Area of Science:
- Pediatrics
- Microbiology
- Immunology
Background:
- Respiratory illnesses are common in children attending day care.
- Probiotics, such as Lactobacillus rhamnosus GG (GG), are being investigated for their potential health benefits.
Purpose of the Study:
- To evaluate the effect of long-term daily consumption of milk containing probiotic Lactobacillus rhamnosus GG (GG) on reducing respiratory illness in children.
Main Methods:
- A randomized, double-blind, placebo-controlled trial involved 523 children aged 2-6 years in Finnish day care centers.
- Participants consumed either regular milk or milk with GG for 28 weeks, with daily symptom recording by parents.
- Analysis included primary outcome data from 501 subjects and completed cases from 128 subjects with confirmed GG recovery in fecal samples.
Main Results:
- In the total population, there was no significant difference in respiratory symptom days between the GG and placebo groups (IRR 0.97; P=0.098).
- However, in the subgroup of completed cases (with fecal GG recovery), the GG group experienced fewer symptom days (IRR 0.83; P<0.001).
Conclusions:
- Lactobacillus rhamnosus GG (GG) consumption demonstrated a reduction in respiratory illness occurrence in children within the completed cases subgroup.
- The study highlights the need for further clinical trials to clarify the link between probiotic fecal recovery and symptom prevalence in children.
Background/Objectives:
To determine whether long-term daily consumption of milk containing probiotic Lactobacillus rhamnosus GG (GG) decreases respiratory illness in children.
Subjects/Methods:
A randomized, double-blind, placebo-controlled trial was conducted with 523 children aged 2-6 years attending day care centers in Finland. Subjects received either normal milk or the same milk with GG on three daily meals for 28 weeks. Daily recording of children' symptoms was done by parents. Primary outcome data from 501 subjects were available for analysis, and data from 128 subjects were analyzed as completed cases in terms of recovery of GG in fecal samples.
Results:
Number of days with at least one respiratory symptom in all subjects was 5.03/month (95% confidence interval (CI): 4.92-5.15) in the GG group and 5.17/month (95% CI: 5.05-5.29) in the placebo group incidence rate ratio (IRR) 0.97; 95% CI: 0.94-1.00; P=0.098). In the completed cases, the figures were 4.71 days/month (95% CI: 4.52-4.90) in the GG group and 5.67 days/month (95% CI: 5.40-5.94) in the placebo group (IRR 0.83; 95% CI: 0.78-0.88; P<0.001).
Conclusions:
Consumption of GG reduced the occurrence of respiratory illness in children attending day care centers in the completed cases subgroup, but not in the total population. Thus, future clinical trials are warranted to clarify the association between fecal recovery of a probiotic and the symptom prevalence.
Related Concept Videos
Microbiota of the Respiratory Tract
Probiotics
Development of Human Microbiota

